consolidated data on isolates |
|
|
Hib Vaccine countries and Non-Hib Vaccine countries
|
|
| Chart 1: A comparison of the proportions of S. pneumoniae (SPN), H. influenzae (HIN) and N.meningitidis (NME) in the Hib Vaccine countries and Non-Hib Vaccine countries. |
The charts shows the proportions of S. pneumoniae, H. influenzae and N.meningitidis isolated from CSF in the 13 sites in Kenya, Uganda, Tanzania and Ethiopia. In Ethiopia and Tanzania, where the conjugate vaccine against HIB has yet to be introduced, HIB is the pre-dominant bacterial cause of meningitis and pneumonia among young children. In Kenya and Uganda where the Hib vaccine is routinely used in child immunization, S. pneumoniae is the leading cause of bacterial meningitis, bacterial pneumonia and sepsis among young children. Very few, if any cases, of N.meningitidis are isolated from the sites in the four countries .
Copyright © 2007 The Network for Surveillance of Pneumococcal Disease in the East African Region . All rights reserved. |
|
|
